Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms

计划入组 1,001 人 · 首次发布于 2021 年 11 月 18 日

Co-administration of IVM and ALB in School-based Deworming in Uganda

计划入组 8,767 人 · 首次发布于 2024 年 7 月 11 日

Evaluation of the effectiveness of ALBENDAZOL-IVERMECTIN co-formulation vs ALBENDAZOLE for the treatment of intestinal worms.

计划入组 1,223 人

Vasoactive intestinal peptide

C₁₄₇H₂₃₇N₄₃O₄₃S

Intestinal trefoil factor

Oral alkaline phosphatase (Synthetic Biologics)

AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP

Australia

GEDII - GRUPO DE ESTUDO DA DOENÇA INFLAMATÓRIA INTESTINAL

Portugal

Evonik Industries Ag

Germany

Novel Mango-Flavored Pill Shows Promise in Eradicating Intestinal Worms

Albendazole-Ivermectin Combination Shows Promise Against Intestinal Worms in Phase II/III Trial

Elanco's Credelio Quattro Breaks New Ground in Multi-Parasite Protection for Dogs